270 related articles for article (PubMed ID: 35087834)
1. Emerging Role of LncRNA Regulation for NLRP3 Inflammasome in Diabetes Complications.
Lu X; Tan Q; Ma J; Zhang J; Yu P
Front Cell Dev Biol; 2021; 9():792401. PubMed ID: 35087834
[TBL] [Abstract][Full Text] [Related]
2. Targeting NLRP3 inflammasome as a promising approach for treatment of diabetic nephropathy: Preclinical evidences with therapeutic approaches.
Ram C; Jha AK; Ghosh A; Gairola S; Syed AM; Murty US; Naidu VGM; Sahu BD
Eur J Pharmacol; 2020 Oct; 885():173503. PubMed ID: 32858047
[TBL] [Abstract][Full Text] [Related]
3. Systematic Analysis of Long Non-Coding RNAs in Inflammasome Activation in Monocytes/Macrophages.
Qian N; Distefano R; Ilieva M; Madsen JH; Rennie S; Uchida S
Noncoding RNA; 2023 Aug; 9(5):. PubMed ID: 37736896
[TBL] [Abstract][Full Text] [Related]
4. Targeting the NLRP3 Inflammasome in Diabetic Nephropathy.
Yang M; Wang X; Han Y; Li C; Wei L; Yang J; Chen W; Zhu X; Sun L
Curr Med Chem; 2021; 28(42):8810-8824. PubMed ID: 34225600
[TBL] [Abstract][Full Text] [Related]
5. Functional crosstalk between Long non-coding RNAs and the NLRP3 inflammasome in the regulation of diseases.
Luo D; Liu F; Zhang J; Shao Q; Tao W; Xiao R; Dai W; Qian K
Mol Immunol; 2021 Mar; 131():191-200. PubMed ID: 33446392
[TBL] [Abstract][Full Text] [Related]
6. NLRP3 inflammasome activation is associated with proliferative diabetic retinopathy.
Loukovaara S; Piippo N; Kinnunen K; Hytti M; Kaarniranta K; Kauppinen A
Acta Ophthalmol; 2017 Dec; 95(8):803-808. PubMed ID: 28271611
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of NLRP3 inflammasome ameliorates podocyte damage by suppressing lipid accumulation in diabetic nephropathy.
Wu M; Yang Z; Zhang C; Shi Y; Han W; Song S; Mu L; Du C; Shi Y
Metabolism; 2021 May; 118():154748. PubMed ID: 33675822
[TBL] [Abstract][Full Text] [Related]
8. Metformin ameliorates the NLPP3 inflammasome mediated pyroptosis by inhibiting the expression of NEK7 in diabetic periodontitis.
Zhou X; Wang Q; Nie L; Zhang P; Zhao P; Yuan Q; Ji N; Ding Y; Wang Q
Arch Oral Biol; 2020 Aug; 116():104763. PubMed ID: 32480011
[TBL] [Abstract][Full Text] [Related]
9. Thrombin receptor PAR4 drives canonical NLRP3 inflammasome signaling in the heart.
Fender AC; Kleeschulte S; Stolte S; Leineweber K; Kamler M; Bode J; Li N; Dobrev D
Basic Res Cardiol; 2020 Jan; 115(2):10. PubMed ID: 31912235
[TBL] [Abstract][Full Text] [Related]
10. Regulation of NLRP3 by non-coding RNAs in different cancers: interplay between non-coding RNAs and NLRP3 in carcinogenesis and metastasis.
Farooqi AA; Attar R; Tanriover G; Sabitaliyevich UY; Zhailganov A; Rabandiyarov M
Cell Mol Biol (Noisy-le-grand); 2020 Dec; 66(8):47-51. PubMed ID: 34174977
[TBL] [Abstract][Full Text] [Related]
11. Rosuvastatin alleviates diabetic cardiomyopathy by inhibiting NLRP3 inflammasome and MAPK pathways in a type 2 diabetes rat model.
Luo B; Li B; Wang W; Liu X; Liu X; Xia Y; Zhang C; Zhang Y; Zhang M; An F
Cardiovasc Drugs Ther; 2014 Feb; 28(1):33-43. PubMed ID: 24254031
[TBL] [Abstract][Full Text] [Related]
12. LincRNA-Gm4419 knockdown ameliorates NF-κB/NLRP3 inflammasome-mediated inflammation in diabetic nephropathy.
Yi H; Peng R; Zhang LY; Sun Y; Peng HM; Liu HD; Yu LJ; Li AL; Zhang YJ; Jiang WH; Zhang Z
Cell Death Dis; 2017 Feb; 8(2):e2583. PubMed ID: 28151474
[TBL] [Abstract][Full Text] [Related]
13. Activation of the TXNIP/NLRP3 inflammasome pathway contributes to inflammation in diabetic retinopathy: a novel inhibitory effect of minocycline.
Chen W; Zhao M; Zhao S; Lu Q; Ni L; Zou C; Lu L; Xu X; Guan H; Zheng Z; Qiu Q
Inflamm Res; 2017 Feb; 66(2):157-166. PubMed ID: 27785530
[TBL] [Abstract][Full Text] [Related]
14. Mitochondria, the NLRP3 Inflammasome, and Sirtuins in Type 2 Diabetes: New Therapeutic Targets.
Rovira-Llopis S; Apostolova N; Bañuls C; Muntané J; Rocha M; Victor VM
Antioxid Redox Signal; 2018 Sep; 29(8):749-791. PubMed ID: 29256638
[TBL] [Abstract][Full Text] [Related]
15. [Molecular regulative mechanisms of NLRP3 inflammasome activation in diabetic nephropathy and interventional effects of Chinese herbal medicine].
Wang WW; Han WB; Wan YG; Tu Y; Liu BH; Liu YL; Wu W; Yee HY; Fang QJ; Yao J
Zhongguo Zhong Yao Za Zhi; 2020 Jan; 45(1):7-13. PubMed ID: 32237405
[TBL] [Abstract][Full Text] [Related]
16. The Role of the NLRP3 Inflammasome in Mediating Glomerular and Tubular Injury in Diabetic Nephropathy.
Williams BM; Cliff CL; Lee K; Squires PE; Hills CE
Front Physiol; 2022; 13():907504. PubMed ID: 35755447
[TBL] [Abstract][Full Text] [Related]
17. Targeting NLRP3 Inflammasome in the Treatment Of Diabetes and Diabetic Complications: Role of Natural Compounds from Herbal Medicine.
Bai Y; Mu Q; Bao X; Zuo J; Fang X; Hua J; Zhang D; Jiang G; Li P; Gao S; Zhao D
Aging Dis; 2021 Oct; 12(7):1587-1604. PubMed ID: 34631209
[TBL] [Abstract][Full Text] [Related]
18. Contribution of redox-dependent activation of endothelial Nlrp3 inflammasomes to hyperglycemia-induced endothelial dysfunction.
Chen Y; Wang L; Pitzer AL; Li X; Li PL; Zhang Y
J Mol Med (Berl); 2016 Dec; 94(12):1335-1347. PubMed ID: 27783111
[TBL] [Abstract][Full Text] [Related]
19. Inhibiting the NLRP3 Inflammasome Activation with MCC950 Ameliorates Diabetic Encephalopathy in db/db Mice.
Zhai Y; Meng X; Ye T; Xie W; Sun G; Sun X
Molecules; 2018 Feb; 23(3):. PubMed ID: 29495433
[TBL] [Abstract][Full Text] [Related]
20. The purinergic 2X7 receptor participates in renal inflammation and injury induced by high-fat diet: possible role of NLRP3 inflammasome activation.
Solini A; Menini S; Rossi C; Ricci C; Santini E; Blasetti Fantauzzi C; Iacobini C; Pugliese G
J Pathol; 2013 Nov; 231(3):342-53. PubMed ID: 23843215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
